X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare AANJANEYA LIFECARE with Natco Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. DATSONS LABS vs NATCO PHARMA - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. DATSONS LABS NATCO PHARMA DR. DATSONS LABS/
NATCO PHARMA
 
P/E (TTM) x -10.9 33.7 - View Chart
P/BV x 0.2 17.2 0.9% View Chart
Dividend Yield % 0.0 0.7 -  

Financials

 DR. DATSONS LABS   NATCO PHARMA
EQUITY SHARE DATA
    DR. DATSONS LABS
Mar-14
NATCO PHARMA
Mar-14
DR. DATSONS LABS/
NATCO PHARMA
5-Yr Chart
Click to enlarge
High Rs126877 14.3%   
Low Rs31424 7.3%   
Sales per share (Unadj.) Rs133.0223.4 59.5%  
Earnings per share (Unadj.) Rs0.231.1 0.5%  
Cash flow per share (Unadj.) Rs6.640.3 16.4%  
Dividends per share (Unadj.) Rs05.00 0.0%  
Dividend yield (eoy) %00.8 0.0%  
Book value per share (Unadj.) Rs128.8219.5 58.7%  
Shares outstanding (eoy) m31.6633.07 95.7%   
Bonus/Rights/Conversions FCCBPA-  
Price / Sales ratio x0.62.9 20.2%   
Avg P/E ratio x516.120.9 2,465.9%  
P/CF ratio (eoy) x11.816.1 73.3%  
Price / Book Value ratio x0.63.0 20.5%  
Dividend payout %016.1 0.0%   
Avg Mkt Cap Rs m2,47721,504 11.5%   
No. of employees `000NANA-   
Total wages/salary Rs m561,128 5.0%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m4,2117,389 57.0%  
Other income Rs m79167 47.1%   
Total revenues Rs m4,2897,556 56.8%   
Gross profit Rs m5691,793 31.7%  
Depreciation Rs m204304 67.1%   
Interest Rs m430366 117.5%   
Profit before tax Rs m131,290 1.0%   
Minority Interest Rs m046 0.0%   
Prior Period Items Rs m-20-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m6309 2.0%   
Profit after tax Rs m51,027 0.5%  
Gross profit margin %13.524.3 55.6%  
Effective tax rate %48.023.9 200.7%   
Net profit margin %0.113.9 0.8%  
BALANCE SHEET DATA
Current assets Rs m6,8523,681 186.1%   
Current liabilities Rs m6,7113,123 214.9%   
Net working cap to sales %3.37.6 44.3%  
Current ratio x1.01.2 86.6%  
Inventory Days Days16189 179.8%  
Debtors Days Days31859 542.7%  
Net fixed assets Rs m3,6737,685 47.8%   
Share capital Rs m317331 95.7%   
"Free" reserves Rs m3,7616,670 56.4%   
Net worth Rs m4,0787,259 56.2%   
Long term debt Rs m1,671955 175.0%   
Total assets Rs m12,63311,957 105.6%  
Interest coverage x1.04.5 22.8%   
Debt to equity ratio x0.40.1 311.5%  
Sales to assets ratio x0.30.6 53.9%   
Return on assets %3.411.7 29.5%  
Return on equity %0.114.2 0.8%  
Return on capital %7.720.7 37.0%  
Exports to sales %22.939.4 58.2%   
Imports to sales %14.35.7 250.8%   
Exports (fob) Rs m9642,908 33.2%   
Imports (cif) Rs m602421 142.9%   
Fx inflow Rs m9643,445 28.0%   
Fx outflow Rs m607703 86.4%   
Net fx Rs m3572,743 13.0%   
CASH FLOW
From Operations Rs m1,3451,440 93.4%  
From Investments Rs m-2,256-1,089 207.1%  
From Financial Activity Rs m-1,200-353 340.2%  
Net Cashflow Rs m-2,111-1 141,657.7%  

Share Holding

Indian Promoters % 4.5 52.0 8.7%  
Foreign collaborators % 0.0 1.5 -  
Indian inst/Mut Fund % 0.0 7.8 -  
FIIs % 1.4 16.6 8.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 94.1 26.0 361.9%  
Shareholders   20,807 25,395 81.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. DATSONS LABS With:   ABBOTT INDIA  JUBILANT LIFE SCIENCES  AJANTA PHARMA  PIRAMAL ENTERPRISES  ALKEM LABORATORIES  

Compare DR. DATSONS LABS With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Weak Finish to the Week Post Vishal Sikka's Exit as CEO of Infosys(Closing)

Share markets in India witnessed selling pressure, led by slump in shares of Infosys Ltd. after Vishal Sikka resigned as chief executive officer of the country's second-largest software services exporter.

Related Views on News

Securities & Intelligence Services Ltd. (IPO)

Jul 31, 2017

Should you subscribe to the IPO of Securities & Intelligence Services Ltd?

Why Super Investors are Underperforming in This Market (The 5 Minute Wrapup)

Jul 8, 2017

If Super Investors can wait for the right pitch, so can you.

Tejas Networks Ltd. (IPO)

Jun 14, 2017

Should you subscribe to the IPO of Tejas Networks Ltd?

Discover the Secrets of Hidden Smallcaps From These AGMs (The 5 Minute Wrapup)

May 26, 2017

Don't be surprised to come across some Super Investors there!

A Trader's Nightmare. A Business Owner's Delight. (The 5 Minute Wrapup)

May 19, 2017

Not all small-cap investors see themselves as traders. Some see themselves as business owners.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

DR. DATSONS LABS SHARE PRICE


May 21, 2015 (Close)

TRACK DR. DATSONS LABS

  • Track your investment in DR. DATSONS LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. DATSONS LABS

DR. DATSONS LABS 8-QTR ANALYSIS

COMPARE DR. DATSONS LABS WITH

MARKET STATS